General Information of the Compound
Compound ID
CP0180420
Compound Name
1-[3-(2-Benzyl-phenoxy)-propyl]-pyrrolidine
    Show/Hide
Synonyms
1-[3-(2-Benzyl-phenoxy)-propyl]-pyrrolidine
CHEMBL187367
ZINC13581632
    Show/Hide
Structure
Formula
C20H25NO
Molecular Weight
295.426
Canonical SMILES
C(COc1ccccc1Cc1ccccc1)CN1CCCC1
    Show/Hide
InChI
InChI=1S/C20H25NO/c1-2-9-18(10-3-1)17-19-11-4-5-12-20(19)22-16-8-15-21-13-6-7-14-21/h1-5,9-12H,6-8,13-17H2
    Show/Hide
InChIKey
SECXHJRGBAZUCO-UHFFFAOYSA-N
Physicochemical Property
logP
4.1421
Rotatable Bonds
7
Heavy Atom Count
22
Polar Areas
12.47
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
2
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11335419
SID: 16426039
ChEMBL ID
CHEMBL187367
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01206, Histamine H1 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
Ki = 10 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 1-[3-(2-Benzyl-phenoxy)-propyl]-pyrrolidine )
Drug Name 1-[3-(2-Benzyl-phenoxy)-propyl]-pyrrolidine
Target(s)
Dopamine D5 receptor (D5R)
Inhibitor
Dopamine D3 receptor (D3R)
Inhibitor
Dopamine D2 receptor (D2R)
Inhibitor
Dopamine D4 receptor (D4R)
Inhibitor
Dopamine D1 receptor (D1R)
Inhibitor